From our General Assembly and #AAIC26 to our mid-term review, ISRCTN study registration, Digital Engagement Platform and AD-RIDDLE Academia, it’s been a busy few months!
➡Read the latest AD-RIDDLE newsletter: mailchi.mp/8e93b3dc99c3...
#WorldAlzMonth #WorldAlzheimersMonth @ihieurope.bsky.social
➡Read the latest AD-RIDDLE newsletter: mailchi.mp/8e93b3dc99c3...
#WorldAlzMonth #WorldAlzheimersMonth @ihieurope.bsky.social
September 30, 2026 at 11:30 AM
From our General Assembly and #AAIC26 to our mid-term review, ISRCTN study registration, Digital Engagement Platform and AD-RIDDLE Academia, it’s been a busy few months!
➡Read the latest AD-RIDDLE newsletter: mailchi.mp/8e93b3dc99c3...
#WorldAlzMonth #WorldAlzheimersMonth @ihieurope.bsky.social
➡Read the latest AD-RIDDLE newsletter: mailchi.mp/8e93b3dc99c3...
#WorldAlzMonth #WorldAlzheimersMonth @ihieurope.bsky.social
Alzheimer’s disease heterogeneity calls for a rethink www.clinicaltrialsarena.com/features/aai...
#Alzheimers #dementia #science #neuroscience #NeuroSkyence
#Alzheimers #dementia #science #neuroscience #NeuroSkyence
AAIC26: Alzheimer’s disease heterogeneity calls for a rethink
While the Alzheimer’s disease care landscape is shifting, gaps to widespread therapeutic availability and imaging remain, said experts at AAIC 2026.
www.clinicaltrialsarena.com
July 31, 2026 at 3:01 PM
Alzheimer’s disease heterogeneity calls for a rethink www.clinicaltrialsarena.com/features/aai...
#Alzheimers #dementia #science #neuroscience #NeuroSkyence
#Alzheimers #dementia #science #neuroscience #NeuroSkyence
Did you hear the news? 🔬
Data from a study reported at #AAIC26 suggests a blood test for Alzheimer’s can improve the accuracy of a diagnosis among specialists and primary care physicians.
We asked the study's lead author Sebastian Palmqvist, M.D., Ph.D., to break down the science.
Data from a study reported at #AAIC26 suggests a blood test for Alzheimer’s can improve the accuracy of a diagnosis among specialists and primary care physicians.
We asked the study's lead author Sebastian Palmqvist, M.D., Ph.D., to break down the science.
July 30, 2026 at 3:35 PM
Did you hear the news? 🔬
Data from a study reported at #AAIC26 suggests a blood test for Alzheimer’s can improve the accuracy of a diagnosis among specialists and primary care physicians.
We asked the study's lead author Sebastian Palmqvist, M.D., Ph.D., to break down the science.
Data from a study reported at #AAIC26 suggests a blood test for Alzheimer’s can improve the accuracy of a diagnosis among specialists and primary care physicians.
We asked the study's lead author Sebastian Palmqvist, M.D., Ph.D., to break down the science.
🥇Massive congratulations @rionamcardle.bsky.social @newcastleuni.bsky.social & @roisinmcmanus.bsky.social @dzne.science joint winners in the Trasna na dTonnta poster competition at #AAIC26 🥳
🎊Sincere thanks to @alzresearchuk.bsky.social for sponsoring the prize! Read more here: tinyurl.com/2upnnp37
🎊Sincere thanks to @alzresearchuk.bsky.social for sponsoring the prize! Read more here: tinyurl.com/2upnnp37
July 30, 2026 at 2:49 PM
🥇Massive congratulations @rionamcardle.bsky.social @newcastleuni.bsky.social & @roisinmcmanus.bsky.social @dzne.science joint winners in the Trasna na dTonnta poster competition at #AAIC26 🥳
🎊Sincere thanks to @alzresearchuk.bsky.social for sponsoring the prize! Read more here: tinyurl.com/2upnnp37
🎊Sincere thanks to @alzresearchuk.bsky.social for sponsoring the prize! Read more here: tinyurl.com/2upnnp37
🆕 #AAIC26 data from the LiBBY trial suggest an oral THC/CBD combination may significantly reduce agitation in hospice-eligible patients with advanced dementia
Read more: www.neurologylive.com/view/thc-cbd...
#Alzheimer #Dementia #Care #ClinicalTrial #Neurology #BrainHealth
Read more: www.neurologylive.com/view/thc-cbd...
#Alzheimer #Dementia #Care #ClinicalTrial #Neurology #BrainHealth
THC/CBD Combination Cuts Agitation in Hospice-Eligible Dementia: LiBBY Trial | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
A 12-week, placebo-controlled phase 2 trial found that an oral THC/CBD combination significantly reduced agitation in hospice-eligible patients with Alzheimer disease and other dementias, meeting its ...
www.neurologylive.com
July 27, 2026 at 1:06 PM
🆕 #AAIC26 data from the LiBBY trial suggest an oral THC/CBD combination may significantly reduce agitation in hospice-eligible patients with advanced dementia
Read more: www.neurologylive.com/view/thc-cbd...
#Alzheimer #Dementia #Care #ClinicalTrial #Neurology #BrainHealth
Read more: www.neurologylive.com/view/thc-cbd...
#Alzheimer #Dementia #Care #ClinicalTrial #Neurology #BrainHealth
Indeed!
Very happy for the opportunity to talk about our latest work on tandem repeats and Alzheimer's disease risk at hashtag#AAIC26 in London last week 🧬🧠
A massive thank you to the Sleegers Lab team and all collaborators who made this work possible!
Very happy for the opportunity to talk about our latest work on tandem repeats and Alzheimer's disease risk at hashtag#AAIC26 in London last week 🧬🧠
A massive thank you to the Sleegers Lab team and all collaborators who made this work possible!
What a fantastic time we had at #AAIC26 in London last week! 🧠🧬
It was incredibly inspiring to connect with the global Alzheimer's disease research community and share our lab's latest work.
It was incredibly inspiring to connect with the global Alzheimer's disease research community and share our lab's latest work.
July 24, 2026 at 1:08 PM
Indeed!
Very happy for the opportunity to talk about our latest work on tandem repeats and Alzheimer's disease risk at hashtag#AAIC26 in London last week 🧬🧠
A massive thank you to the Sleegers Lab team and all collaborators who made this work possible!
Very happy for the opportunity to talk about our latest work on tandem repeats and Alzheimer's disease risk at hashtag#AAIC26 in London last week 🧬🧠
A massive thank you to the Sleegers Lab team and all collaborators who made this work possible!
What a fantastic time we had at #AAIC26 in London last week! 🧠🧬
It was incredibly inspiring to connect with the global Alzheimer's disease research community and share our lab's latest work.
It was incredibly inspiring to connect with the global Alzheimer's disease research community and share our lab's latest work.
July 24, 2026 at 1:06 PM
What a fantastic time we had at #AAIC26 in London last week! 🧠🧬
It was incredibly inspiring to connect with the global Alzheimer's disease research community and share our lab's latest work.
It was incredibly inspiring to connect with the global Alzheimer's disease research community and share our lab's latest work.
At #AAIC26 last week, we announced PROTECT-Cog to evaluate whether combining lifestyle intervention with a metabolism-targeting drug like a GLP-1 agonist can further reduce dementia risk. That’s a $100 million commitment – in science, progress, and people.
📰 Today the Association announced the launch of the PROTECT-Cog Study to test U.S. POINTER lifestyle and GLP-1 or similar drug to cut risk of cognitive decline. Learn More: https://bit.ly/4pekZiJ
July 23, 2026 at 9:04 PM
At #AAIC26 last week, we announced PROTECT-Cog to evaluate whether combining lifestyle intervention with a metabolism-targeting drug like a GLP-1 agonist can further reduce dementia risk. That’s a $100 million commitment – in science, progress, and people.
The FTD Disorders Registry was proud to present new research at #AAIC26!
Our poster demonstrates how we are helping researchers connect with a growing, research-ready FTD community & providing valuable insights to support study recruitment.
View the poster:
ftdregistry.org/press/ftd-di...
#endFTD
Our poster demonstrates how we are helping researchers connect with a growing, research-ready FTD community & providing valuable insights to support study recruitment.
View the poster:
ftdregistry.org/press/ftd-di...
#endFTD
July 23, 2026 at 12:03 PM
The FTD Disorders Registry was proud to present new research at #AAIC26!
Our poster demonstrates how we are helping researchers connect with a growing, research-ready FTD community & providing valuable insights to support study recruitment.
View the poster:
ftdregistry.org/press/ftd-di...
#endFTD
Our poster demonstrates how we are helping researchers connect with a growing, research-ready FTD community & providing valuable insights to support study recruitment.
View the poster:
ftdregistry.org/press/ftd-di...
#endFTD
🔬 Did you catch last week's exciting research news? A study reported at #AAIC26 suggests an Alzheimer’s blood test may help predict future Alzheimer’s risk before memory or thinking problems begin.
Watch the study's senior author Reisa Sperling, Ph.D., break down the research.
Watch the study's senior author Reisa Sperling, Ph.D., break down the research.
July 22, 2026 at 11:21 PM
🔬 Did you catch last week's exciting research news? A study reported at #AAIC26 suggests an Alzheimer’s blood test may help predict future Alzheimer’s risk before memory or thinking problems begin.
Watch the study's senior author Reisa Sperling, Ph.D., break down the research.
Watch the study's senior author Reisa Sperling, Ph.D., break down the research.
Dr Clíona Farrell went to #AAIC26 all week, then ended it at a cabaret about familial Alzheimer's. She expected to cry. She didn't expect to laugh as much as she did. Her blog on Unforgettable is now live.
pod.fo/e/48ee7b
pod.fo/e/48ee7b
Dementia Researcher Blogs: Dr Clíona Farrell - An Alzheimer’s Cabaret
Dr Clíona Farrell narrates her blog written for Dementia Researcher.After a long week at AAIC in London, Clíona swapped the conference hall for the Bloomsbury Theatre and a one-woman cabaret call...
pod.fo
July 22, 2026 at 9:56 PM
Dr Clíona Farrell went to #AAIC26 all week, then ended it at a cabaret about familial Alzheimer's. She expected to cry. She didn't expect to laugh as much as she did. Her blog on Unforgettable is now live.
pod.fo/e/48ee7b
pod.fo/e/48ee7b
💻 Supervised vs. unsupervised digital assessments in ADRD: what's the verdict?
On PIA Day at #AAIC26, the Cognition PIA & @SCD_PIA hosted a lively joint debate led by Ph. D. Emily Paolillo, followed by a great Q&A.
Thanks to all who joined the debate!
@istaart.bsky.social
#ISTAART #DigitalHealth
On PIA Day at #AAIC26, the Cognition PIA & @SCD_PIA hosted a lively joint debate led by Ph. D. Emily Paolillo, followed by a great Q&A.
Thanks to all who joined the debate!
@istaart.bsky.social
#ISTAART #DigitalHealth
July 21, 2026 at 7:36 PM
💻 Supervised vs. unsupervised digital assessments in ADRD: what's the verdict?
On PIA Day at #AAIC26, the Cognition PIA & @SCD_PIA hosted a lively joint debate led by Ph. D. Emily Paolillo, followed by a great Q&A.
Thanks to all who joined the debate!
@istaart.bsky.social
#ISTAART #DigitalHealth
On PIA Day at #AAIC26, the Cognition PIA & @SCD_PIA hosted a lively joint debate led by Ph. D. Emily Paolillo, followed by a great Q&A.
Thanks to all who joined the debate!
@istaart.bsky.social
#ISTAART #DigitalHealth
Standardizing language biomarkers in ADRD! 🗣️
At #AAIC26, our Immersive Workshop convened clinicians, linguists & data scientists to shape standardized speech/language recommendations.
Thanks to A. König, A. Garcia & S. Alexopoulou!
@istaart.bsky.social
#ISTAART #CognitionPIA #DigitalHealth
At #AAIC26, our Immersive Workshop convened clinicians, linguists & data scientists to shape standardized speech/language recommendations.
Thanks to A. König, A. Garcia & S. Alexopoulou!
@istaart.bsky.social
#ISTAART #CognitionPIA #DigitalHealth
July 21, 2026 at 7:24 PM
Standardizing language biomarkers in ADRD! 🗣️
At #AAIC26, our Immersive Workshop convened clinicians, linguists & data scientists to shape standardized speech/language recommendations.
Thanks to A. König, A. Garcia & S. Alexopoulou!
@istaart.bsky.social
#ISTAART #CognitionPIA #DigitalHealth
At #AAIC26, our Immersive Workshop convened clinicians, linguists & data scientists to shape standardized speech/language recommendations.
Thanks to A. König, A. Garcia & S. Alexopoulou!
@istaart.bsky.social
#ISTAART #CognitionPIA #DigitalHealth
Great turnout for our #AAIC26 workshop: "Measuring What Matters: Evaluating, Selecting and Developing Cognitive Outcome Measures"! 🧠
Thanks to leaders @roosjutten.bsky.social, Sietske Sikkes & Laura Rabin for an insightful session.
@istaart.bsky.social
#ISTAART #CognitionPIA #Psychometrics
Thanks to leaders @roosjutten.bsky.social, Sietske Sikkes & Laura Rabin for an insightful session.
@istaart.bsky.social
#ISTAART #CognitionPIA #Psychometrics
July 21, 2026 at 6:59 PM
Great turnout for our #AAIC26 workshop: "Measuring What Matters: Evaluating, Selecting and Developing Cognitive Outcome Measures"! 🧠
Thanks to leaders @roosjutten.bsky.social, Sietske Sikkes & Laura Rabin for an insightful session.
@istaart.bsky.social
#ISTAART #CognitionPIA #Psychometrics
Thanks to leaders @roosjutten.bsky.social, Sietske Sikkes & Laura Rabin for an insightful session.
@istaart.bsky.social
#ISTAART #CognitionPIA #Psychometrics
Blood test results helped primary care physicians diagnose Alzheimer's disease with nearly the same accuracy as specialists, a study of Swedish patients with cognitive impairment showed. #AAIC26
https://www.medpagetoday.com/meetingcoverage/aaic/122227
https://www.medpagetoday.com/meetingcoverage/aaic/122227
Alzheimer's Blood Tests Help Primary Care Doctors Make Better Diagnoses
Physicians changed diagnosis in 30% of patients after seeing blood test results
www.medpagetoday.com
July 19, 2026 at 9:50 PM
Blood test results helped primary care physicians diagnose Alzheimer's disease with nearly the same accuracy as specialists, a study of Swedish patients with cognitive impairment showed. #AAIC26
https://www.medpagetoday.com/meetingcoverage/aaic/122227
https://www.medpagetoday.com/meetingcoverage/aaic/122227
Had a blast attending #AAIC26 and presenting my @ucc.ie postdoctoral work on how the gut microbiome and sex differences may be intertwined in Alzheimer’s disease progression. Also great seeing familiar faces and connecting with new ones. 10/10 experience ✨
@alzassociation.bsky.social
@alzassociation.bsky.social
July 17, 2026 at 4:07 PM
Had a blast attending #AAIC26 and presenting my @ucc.ie postdoctoral work on how the gut microbiome and sex differences may be intertwined in Alzheimer’s disease progression. Also great seeing familiar faces and connecting with new ones. 10/10 experience ✨
@alzassociation.bsky.social
@alzassociation.bsky.social
Several epidemiology studies suggest that #shingles vaccines can reduce the risk of #Alzheimers. Now GSK is running a 33,600-person clinical trial to see if its #Shingrix vaccine can prevent dementia. Read more in my latest for @endpts.com: endpoints.news/gsk-plans-la... #AAIC26
Can the shingles vaccine prevent Alzheimer’s? GSK has a big study to find out
GSK has launched a 33,600-person Finland trial of Shingrix to test if shingles vaccine reduces dementia risk in those 76+.
endpoints.news
July 17, 2026 at 3:01 PM
Several epidemiology studies suggest that #shingles vaccines can reduce the risk of #Alzheimers. Now GSK is running a 33,600-person clinical trial to see if its #Shingrix vaccine can prevent dementia. Read more in my latest for @endpts.com: endpoints.news/gsk-plans-la... #AAIC26
That's a wrap on #AAIC26!
Yesterday, Conor Durkin presented at #AAICforAll, a free community event highlighting research from the main conference.
Thank you to everyone who has been involved in this research, especially our PPI group members Paul, Kate and Karen.
tinyurl.com/retdw5k7
Yesterday, Conor Durkin presented at #AAICforAll, a free community event highlighting research from the main conference.
Thank you to everyone who has been involved in this research, especially our PPI group members Paul, Kate and Karen.
tinyurl.com/retdw5k7
#aaicforall #aaic26 #denpruqm | Conor Durkin
This week I had the fantastic opportunity to present at #AAICforAll, a free community event highlighting research from #AAIC26. Our study was a collaboration between #denpruQM and the Department of He...
tinyurl.com
July 17, 2026 at 2:11 PM
That's a wrap on #AAIC26!
Yesterday, Conor Durkin presented at #AAICforAll, a free community event highlighting research from the main conference.
Thank you to everyone who has been involved in this research, especially our PPI group members Paul, Kate and Karen.
tinyurl.com/retdw5k7
Yesterday, Conor Durkin presented at #AAICforAll, a free community event highlighting research from the main conference.
Thank you to everyone who has been involved in this research, especially our PPI group members Paul, Kate and Karen.
tinyurl.com/retdw5k7
This week, more than 13,000 of the brightest minds in dementia science came together for #AAIC26. 🔬 Together, they’re shaping the future of dementia science and clinical care. We leave inspired and energized by the momentum driving Alzheimer’s and dementia research forward. 💜
July 16, 2026 at 10:41 PM
This week, more than 13,000 of the brightest minds in dementia science came together for #AAIC26. 🔬 Together, they’re shaping the future of dementia science and clinical care. We leave inspired and energized by the momentum driving Alzheimer’s and dementia research forward. 💜
A&D Journal Family hosted several wonderful events at #AAIC26! Thank you for your engagement!👏
A&D supported by the incredible authors, editors, & editorial boards of A&D, TRCI, DADM, and BSEA!
Thank you to all editors for their dedication to clear and accurate scientific publications!
A&D supported by the incredible authors, editors, & editorial boards of A&D, TRCI, DADM, and BSEA!
Thank you to all editors for their dedication to clear and accurate scientific publications!
July 16, 2026 at 9:07 PM
A&D Journal Family hosted several wonderful events at #AAIC26! Thank you for your engagement!👏
A&D supported by the incredible authors, editors, & editorial boards of A&D, TRCI, DADM, and BSEA!
Thank you to all editors for their dedication to clear and accurate scientific publications!
A&D supported by the incredible authors, editors, & editorial boards of A&D, TRCI, DADM, and BSEA!
Thank you to all editors for their dedication to clear and accurate scientific publications!
@rebeccahenrys114.bsky.social thank you for your @lbc.co.uk coverage of the LatAM-FINGERS study presented at #AAIC26 that demonstrates that an evidence-based lifestyle program improves brain health among older adults at risk for dementia.
www.lbc.co.uk/article/exer...
www.lbc.co.uk/article/exer...
Structured exercise and diet ‘boosts memory in those with dementia risk’ | LBC
Alzheimer’s Society estimates that about a million people in the UK have dementia
www.lbc.co.uk
July 16, 2026 at 4:44 PM
@rebeccahenrys114.bsky.social thank you for your @lbc.co.uk coverage of the LatAM-FINGERS study presented at #AAIC26 that demonstrates that an evidence-based lifestyle program improves brain health among older adults at risk for dementia.
www.lbc.co.uk/article/exer...
www.lbc.co.uk/article/exer...
Two years ago, Betty Tijms discovered five distinct subtypes of #Alzheimers disease based on proteins found in spinal fluid. At #AAIC26, she told me its time for drugmakers to stop treating Alzheimer’s as a single disease. Read more in my Q&A in @endpts: endpoints.news/qa-betty-tij...
Q&A: Betty Tijms says it’s time to stop treating Alzheimer’s as a single disease
We interview Betty Tijms of Alzheimer Center Amsterdam, who has identified 5 Alzheimer's subtypes and urges drugmakers to treat the condition as multiple diseases for better trials.
endpoints.news
July 16, 2026 at 3:43 PM
Two years ago, Betty Tijms discovered five distinct subtypes of #Alzheimers disease based on proteins found in spinal fluid. At #AAIC26, she told me its time for drugmakers to stop treating Alzheimer’s as a single disease. Read more in my Q&A in @endpts: endpoints.news/qa-betty-tij...
Two years ago, Betty Tijms discovered five distinct subtypes of #Alzheimers disease based on proteins found in spinal fluid. At #AAIC26, she told me its time for drugmakers to stop treating Alzheimer’s as a single disease. Read more in my Q&A in @endpts.com: endpoints.news/qa-betty-tij...
Q&A: Betty Tijms says it’s time to stop treating Alzheimer’s as a single disease
We interview Betty Tijms of Alzheimer Center Amsterdam, who has identified 5 Alzheimer's subtypes and urges drugmakers to treat the condition as multiple diseases for better trials.
endpoints.news
July 16, 2026 at 3:42 PM
Two years ago, Betty Tijms discovered five distinct subtypes of #Alzheimers disease based on proteins found in spinal fluid. At #AAIC26, she told me its time for drugmakers to stop treating Alzheimer’s as a single disease. Read more in my Q&A in @endpts.com: endpoints.news/qa-betty-tij...